Your browser doesn't support javascript.
loading
Chronic model of tympanic perforation in rats with mitomycin C and dexamethasone.
Esteban, Tomás; Atucha, Noemí M; Moraleda, José María; García-Estañ, Joaquín; Insausti, Carmen L; Moraleda-Deleyto, Javier.
Affiliation
  • Esteban T; Servicio de Otorinolaringología, Hospital General Universitario Santa Lucía, Cartagena, Spain.
  • Atucha NM; Departamento de Fisiología, Facultad de Medicina, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, 30120, El Palmar, Murcia, Spain.
  • Moraleda JM; Departamento de Medicina, Facultad de Medicina, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, 30120, El Palmar, Murcia, Spain.
  • García-Estañ J; Departamento de Fisiología, Facultad de Medicina, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, 30120, El Palmar, Murcia, Spain.
  • Insausti CL; Departamento de Medicina, Facultad de Medicina, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria, 30120, El Palmar, Murcia, Spain.
  • Moraleda-Deleyto J; ENT Service, University Hospital of Lewisham, London, UK.
J Otol ; 14(1): 12-16, 2019 Mar.
Article de En | MEDLINE | ID: mdl-30936896
ABSTRACT
A rat model of chronic tympanic membrane perforation was developed to be used in the search of new materials for the sealing of these perforations. A longitudinal study was carried out in rats subjected to incisional myringotomy followed by the application of mitomycin C alone or with dexamethasone. Rats were checked at days 3, 7, 10, 14 and weekly thereafter until perforation closure, for up to 6 months. The addition of dexamethasone is a key component in order to obtain a chronic opening. Myringotomies treated with saline had a mean healing time of 8.5 days. At 8 weeks, between 62.5% and 77.7% of tympanic membranes treated with mitomycin C and dexamethasone remained perforated and at 6 months this number fell to 21.4%. This technique is able to maintain most tympanic membrane perforations patent for at least 8 weeks. This rat model is adequate for its use in preclinical or translational research.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies Langue: En Journal: J Otol Année: 2019 Type de document: Article Pays d'affiliation: Espagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies Langue: En Journal: J Otol Année: 2019 Type de document: Article Pays d'affiliation: Espagne